Zaxine 550 mg (rifaximin) is a long-term antibiotic treatment drug for adults living with HE, a complication of liver disease (cirrhosis).

Ranbaxy, founded by the family of Malvinder and Shivinder Mohan Singh, was at the centre of most of the developments for major part of the ...

Despite the concerns on import alerts from the USFDA and recent drug recalls, the pharma sector was one of the top performers in the last q...

'We do keep talking to various big pharma companies for various kinds of alliance. So potentially I cannot speak about any deal until it ac...

What does Crofelemer approval mean for Glenmark?

"There is another $6 million that Salix is likely to pay us for the facility that we are working on for the supplies of Crofelemer."

Glenmark is going full steam ahead with the launch of Crofelemer post the issue of Napo Pharma's claim of termination of the deal.

In an interview with ET Now, Glenn Saldanha, Chairman and Managing Director, Glenmark, gives his views on the company's strategies. Excerpt...

Glenmark’s partners — US-based Napo Pharmaceuticals and Salix Pharmaceuticals — have announced completion of phase-III trials for the drug ...

Glen Saldanha, Managing Director & CEO, Glenmark Pharmaceuticals speaks to ET Now. Excepts from the interview.

ICICI Venture has made the first buyout by an Indian private equity firm in the international market.